Sunday, September 6, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· June 26, 2026

NEM vs. KGC: Which Gold Mining Stock Should You Bet on Now?

View original at finance.yahoo.com
NEM vs. KGC: Which Gold Mining Stock Should You Bet on Now? Newmont Corporation NEM and Kinross Gold Corporation KGC are two prominent players in the gold mining space with global operations and diversified portfolios…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Newmont anticipates gold production of approximately 5.26 million ounces for full-year 2026, a year-over-year decline from 5.89 million ounces in 2025

    60% confidence
  • Newmont generated $3.6 billion from portfolio optimization actions in 2025, shifting strategic focus to Tier 1 assets

    60% confidence
  • Newmont expects lower production from Penasquito and Cadia in 2026 due to site transitions, as well as lower-than-expected production from Nevada Gold Mines and Pueblo Viejo; these will be partly offset by contributions from Ahafo North

    60% confidence
  • Newmont expects second-quarter 2026 production to be below the first-quarter level

    60% confidence
  • Newmont had total liquidity of roughly $12.8 billion at end of Q1 2026, including cash and cash equivalents of approximately $8.8 billion

    60% confidence
  • Newmont reported a roughly 16% year-over-year and 10% sequential decline in attributable gold production to 1.3 million ounces in Q1 2026, partly linked to strategic divestment of non-core assets

    60% confidence
  • Newmont expects to make a final investment decision on the Red Chris Block Cave Project later in 2026

    60% confidence
  • The Federal Reserve signaled a potential interest rate increase before year-end 2026 while leaving rates unchanged at its most recent policy meeting

    60% confidence
  • Free cash flow surged 161% year over year to a record $3.1 billion in Q1 2026

    60% confidence
  • Ahafo North is expected to produce between 275,000 and 325,000 ounces of gold annually over an estimated mine life of 13 years

    60% confidence
  • Newmont has executed buybacks of $6 billion under earlier authorized share repurchase programs, including $2.4 billion since the fourth-quarter 2025 earnings call; board approved an additional $6 billion repurchase program

    60% confidence
  • Ahafo North output is expected to be 315,000 ounces in 2026, with a ramp-up to full capacity

    60% confidence

Data points we hold from this source

Newmont Corporation · new buyback program6.0 USD
Newmont Corporation · buybacks executed6.0 USD
Newmont Corporation · gold production oz guidance5260000 oz
Newmont Corporation · buybacks since q4 2025 earnings2.4 USD
Newmont Corporation · shareholder distributions2.7 USD
Newmont Corporation · payout ratio12 percent
Newmont Corporation · fcf growth yoy161 percent
Newmont Corporation · total liquidity12.8 USD
Newmont Corporation · free cash flow3.1 USD
Newmont Corporation · gold production oz1300000 oz
Newmont Corporation · gold production yoy decline16 percent
Newmont Corporation · operating cash flow3.8 USD
Newmont Corporation · net cash position3.2 USD
Newmont Corporation · debt reduction42 USD
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Capital Surge Meets Investor Caution: Record Funding Rounds and Government Contracts Amid Valuation Skepticism
A single-week cluster of large AI/fintech funding rounds (Socure, Stability AI, Emerald AI, Generalist AI, Instinct, Gatik, Regent Craft) shows venture capital still pouring into AI infrastructure, identity, and autonomy plays, while Palantir's Army TITAN contract win coincided with a 6% stock drop — signaling that even flagship AI-defense revenue isn't immune to market reassessment of AI valuations. Efficiency-focused innovations like Multiverse Computing's model compression suggest the sector is also pivoting toward cost/inference economics as capital intensity draws scrutiny.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
The same metric (eps) for the same entity (Morgan Stanley & Co. LLC) reported for the identical fiscal period (Q1 2026) and observation date (2026-03-31) has two conflicting values: 3.43 USD_per_share vs 3.08 USD. This is not a temporal change — both observations claim to measure the same point in time. The ~10% discrepancy (0.35 USD difference) is material for a financial metric.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,273 source documents archived
Query this data → isubstrate.com